Gilead trial for Covid-19 meets primary endpoint 29-Apr-20 06:17 pm Analysis Anirudh Sethi Tags#Clinical endpoint #Clinical trials #Endpoint #Medical research #Medical statistics #Nucleotides #Organic compounds #OrganophosphatesPush stocks higherGilead Remdesivir trial for Covid-19 has met primary endpointStudy to provide info on 5-day duration of therapywill share added Remdesivir data from phase 3 shortlySeees data from 2nd simple study at the end of May
Install
